Intravitreal Injection Delivery: Best Practices and Latest Developments – Highlights from an Expert Roundtable Discussion at Macula Society 2020

1.00 CME
60 MINS
$0 FEE
SAVE
banner

Overview

  global ivista

This activity is jointly provided by Global Education Group and iVista Medical Education, Inc.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Launch date: April 27, 2020 
Expiration Date: April 27, 2021


Activity Description

This activity will focus on providing an overview regarding best practices around intravitreal injection, as well as latest developments regarding the use of prefilled syringes, including advantages and implementation into clinical practice.


Target Audience

The educational design of this activity addresses the needs of Retina specialists, comprehensive ophthalmologists, retina fellows, and healthcare providers who are interested in applying the most recent advancements in the retinal medicine field.


Educational Objectives

After completing this activity, the participant should be better able to:

  • Identify the best practices around intravitreal injection delivery 
  • Review the advantages and disadvantages of using a prefilled syringe in clinical practice
  • Review the rates of endophthalmitis between those patients treated without a prefilled syringe versus with a prefilled syringe
  • Identify best practices regarding how to implement prefilled syringes into their practice

Faculty

singh
Rishi P. Singh, MD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Chair & Moderator

baumal
Caroline R. Baumal, MD
Tufts Medical Center
Boston, MA

dilsher
Dilsher S. Dhoot, MD
California Retina Consultants
Visalia, CA

lim
Jennifer I. Lim, MD
University of Illinois at Chicago
Chicago, IL

rosenfeld
Philip Rosenfeld, MD, PhD
Bascom Palmer Eye Institute’s
Miami, FL


Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and iVista Medical Education.  Global is accredited by the ACCME to provide continuing medical education for physicians.


Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Term of Offering

This activity was released on April 27, 2020 and is valid for one year. Requests for credit must be made no later than April 27, 2021. 


Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.


Instructions to Receive Credit

In order to receive credit for this activity, the participant must read the content, score 80% or better on the posttest, and complete the program evaluation. 


Fee Information& Refund/Cancellation Policy

There is no fee for this educational activity.


Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter

Reported Financial Relationship

Caroline Baumal, MD

Speaker's Bureau: Genentech, Novartis, Zeiss
Advisory Board: Genentech, Novartis

Disher Dhoot, MD

Consultant/Independent Contractor: Alimera, Allergan, Eyepoint, Genentech, Novartis, Ocular, Regeneron, Thereapeutix, Santen Grant/Research Support: Genentech, Regeneron
Honoraria: Alimera, Allergan, Eyepoint, Genentech, Novartis, Ocular Thereapeutix, Regeneron, Santen,
Speaker's Bureau: Alimera, Eyepoint, Genentech, Novartis, Regeneron
Advisory Board: Alimera, Allergan, Eyepoint, Genentech, Novartis, Ocular Thereapeutix, Regeneron, Santen
Stock Shareholder: Vortex Surgical

Jennifer Lim, MD

Consultant/Independent Contractor: Aura Biosciences, Ophthea, Quark, Santen,
Grant/Research Support: Chendu Pharmaceuticals, Genentech, Graybug, Regeneron, Stealth
Honoraria: Alcon
Speakers' Bureau: Genentech
Advisory Board: Allergan, Kodiak, Novartis

Rishi P Singh, MD

Consultant/Independent Contractor: Alcon, Baush and Lomb, Novartis, Regeneron,
Grant/Research Support: Apellis, Graybug

Philip J. Rosenfeld, MD

Consultant/Independent Contractor: Carl Zeiss Meditec
Grant/Research Support: Carl Zeiss Meditec

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager

Reported Financial Relationship

Lindsay Borvansky

Nothing to disclose

Andrea Funk

Nothing to disclose

Liddy Knight

Nothing to disclose

Ashley Cann

Nothing to disclose

Alana Ochoa

Nothing to disclose

Yaremi Koopot

Nothing to disclose

Paula Soto

Nothing to disclose


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and iVista Medical Education do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


System/Technical Requirements for Viewing the Activity

  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.